SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The project was established through the BAGS.FM app which is platform that allows projects to create projects with cause, our project directly generates trading fees and processes them through the BAGS app to directly donate towards the official Dolphin Project - We're the first crypto token to passively provide donations and change to acquatic life and have already raised $8,000 towards providing sactuary for captured dolphins.

Dolphin

Dolphin Crypto ($DOLPHIN) is trending amid community excitement, with many highlighting its bullish chart and potential for a breakout. Talk centers on explosive momentum and a possible 'mega pump,' with some suggesting it could be the next meme coin to surge within the Solana ecosystem.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

CRML is trending due to speculation surrounding potential U.S. government investment in Greenland's rare earth minerals and its impact on CRML. The community is discussing the connection between CRML and European Lithium ($EULIF), with some suggesting $EULIF is undervalued given its stake in CRML. Interest in rare earth minerals and the geopolitical importance of Greenland's resources are driving broader discussion.

Australian Dollar Stablecoins. Representing one of the largest sovereign currencies in the APAC region on the blockchain.

Novatti Australian Digital Dollar

Novatti Australian Digital Dollar ($AUDD) is trending as traders discuss the recent volatility and restrictions, such as "cancel-only mode", imposed by Coinbase. The community is drawing parallels to past situations with other tokens and speculating about potential exchange manipulation and legal action. Despite being marketed as a stablecoin, its price fluctuations are fueling both excitement and concern.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending due to community discussions surrounding its technical chart patterns, potential FDA catalysts, and speculation about a possible buyout. Community members are analyzing trendlines and Fibonacci levels to predict short-term price movements, while also awaiting FDA decisions on pending drug applications. Some investors believe the company is undervalued, citing its cash position and revenue potential, while others express frustration with management's decisions.

Maplebear, Inc. engages in the design and development of an online application that offers grocery delivery and pick-up services. The firm offers Instacart which enables users to connect with personal shoppers in the area who pick up and deliver groceries from local stores. The company was founded by Apoorva Mehta, Brandon Leonardo, and Max Mullen in 2012 and is headquartered in San Francisco, CA.

Maplebear Inc.

Instacart

Instacart is trending amid analyst rating updates and discussions around increasing competition, particularly from Amazon and DoorDash. The community is actively debating the company's long-term prospects, weighing its strengths in grocery delivery against potential market share erosion. Some analysts highlight Instacart's potential for growth and profitability, while others express concerns about valuation and competitive pressures.

Bitcoin is the first successful internet money based on peer-to-peer technology; whereby no central bank or authority is involved in the transaction and production of the Bitcoin currency. It was created by an anonymous individual/group under the name, Satoshi Nakamoto. The source code is available publicly as an open source project, anybody can look at it and be part of the developmental process.  Bitcoin is changing the way we see money as we speak. The idea was to produce a means of exchange, independent of any central authority, that could be transferred electronically in a secure, verifiable and immutable way. It is a decentralized peer-to-peer internet currency making mobile payment easy, very low transaction fees, protects your identity, and it works anywhere all the time with no central authority and banks.  Bitcoin is designed to have only 21 million BTC ever created, thus making it a deflationary currency. Bitcoin uses the SHA-256 hashing algorithm with an average transaction confirmation time of 10 minutes. Miners today are mining Bitcoin using ASIC chip dedicated to only mining Bitcoin, and the hash rate has shot up to peta hashes.  Being the first successful online cryptography currency, Bitcoin has inspired other alternative currencies such as Litecoin, Peercoin, Primecoin, and so on.  The cryptocurrency then took off with the innovation of the turing-complete smart contract by Ethereum which led to the development of other amazing projects such as EOS, Tron, and even crypto-collectibles such as CryptoKitties.

Bitcoin

Bitcoin is trending as it approaches previous all-time highs, sparking excitement and debate within the community about its potential to reach new record levels. Community members are actively discussing strategies, potential pullbacks, and the impact of external factors like the government shutdown. The overall sentiment appears bullish, with many anticipating further upward momentum.

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.

Anavex Life Sciences Corporation

Anavex Life Sciences Corp

AVXL is trending as investors closely monitor the progress of blarcamesine, a drug for Alzheimer's, through the EMA approval process, with some anticipating a decision possibly in November. Community discussions revolve around the potential for a significant short squeeze upon approval and speculation about partnership or buyout scenarios. Some are drawing comparisons to Cerevel's buyout by AbbVie, suggesting a potential high valuation for Anavex, with others excited about recent phase 2 trial results for schizophrenia.

SSgA Active Trust - Health Care Select Sector SPDR

Health Care Select Sector SPDR Fund

The health care sector, represented by XLV, is trending amid discussions of defensive rotation and potential undervaluation compared to other sectors. Community members are weighing the impact of potential government policy changes and analyzing technical indicators for signs of a breakout, while also monitoring individual stocks within the sector.

FLOKI is the utility token of the Floki Ecosystem. The Floki Ecosystem is a community-powered ecosystem that aims to give people control of their finances through four key utility offerings:  - The Valhalla NFT Metaverse Game. - The Floki University Crypto Education platform. - DeFi. - The FlokiPlaces NFT & Merchandise Marketplace.

Floki Token

Floki is trending as the community rallies around its recent listing on Robinhood and anticipates the impact of upcoming product launches with burn mechanisms. Bullish investors are closely watching key resistance levels, while some traders highlight the potential for a major move fueled by broader market catalysts and the ongoing 'meme war'. Discussions also mention Floki's utility, ecosystem, and comparisons to other meme coins like DOGE and SHIB.

Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company, which engages in the provision of development and commercialization of therapies for the treatment of neurological disorders. Its product, WAKIX, is a molecule with a novel mechanism of action designed to increase histamine signaling in the brain by binding to H3 receptors. The company was founded by Jeffrey S. Aronin on July 25, 2017 and is headquartered in Plymouth Meeting, PA.

Harmony Biosciences Holdings Inc

Harmony Biosciences is trending as the company's experimental drug for Fragile X syndrome faces trial setbacks, causing a stock slump. Despite this, the community is weighing the potential of their existing product, Wakix, pipeline assets in epilepsy, and overall value play given the low P/E ratio. Bullish investors believe the selloff is an overreaction, viewing it as a buying opportunity.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Strength Seen in Nu Skin (NUS): Can Its 6.2% Jump Turn into More Strength?

Nu Skin (NUS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Coty (COTY) Up 12.1% Since Last Earnings Report: Can It Continue?

Coty (COTY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Shares of Nu Skin Enterprises Inc. ($NUS) surged more than 24% in after-hours trading on Thursday after the company’s better-than-expected fourth-quarter earnings, lifting retail sentiment.Nu Skin Q4 earnings per share came in at $0.38, beating consensus estimates of $0.22, while revenues stood at $445.55 million, surpassing estimates of $436.05 million, according to Stocktwits data.Its board declared a quarterly cash dividend of $0.06 per share, which will be paid on March 5, 2025, to shareholders of record on Feb. 24, 2025.“We were pleased to beat our fourth quarter revenue guidance, generate sequential revenue growth and exceed our adjusted earnings as we materially completed our restructuring plan," said Ryan Napierski, Nu Skin president and CEO. “As we look ahead to 2025, we anticipate improving business trends and a return to year-over-year growth in several of our markets but also anticipate continued economic challenges and poor consumer sentiment, particularly in Greater China and South Korea.Nu Skin plans to focus on strengthening its core business with the rollout of its sales performance compensation plan in several markets and accelerating growth in developing markets including Latin America, added Napierski.For 2025, its annual revenue guidance is $1.48 to $1.62 billion, with about 3% of foreign currency headwind. That is below the $1.7 billion expected by analysts, according to Fly.com.The company expects adjusted EPS to be $0.90 to $1.30, excluding the gain from the sale of Mavely. That compares to consensus estimates of $0.76.Sentiment on Stocktwits improved to ‘extremely bullish’ from ‘bearish’ a week ago. Message volumes climbed to the ‘high’ territory from ‘low.’<figure class="image"><img style="aspect-ratio:1324/302;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2025_02_14_at_6_37_05_AM_6dbe77d445.png" alt="Screenshot 2025-02-14 at 6.37.05 AM.png" width="1324" height="302"><figcaption>NUS sentiment meter and message volumes on Feb 13</figcaption></figure><stembedurl>https://stocktwits.com/fer69/message/604222159</stembedurl>Nu Skin Enterprises, focused on beauty and wellness, operates Nu Skin and Rhyz Inc., operating in nearly 50 markets worldwide.Nu Skin stock is down 6.8% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

(Photo Illustration by Igor Golovniov/SOPA Images/LightRocket via Getty Images)

Nu Skin Stock Surges After-Hours On Strong Q4 Performance: Retail Cheers

For 2025, its annual revenue guidance is $1.48 to $1.62 billion, with about 3% of foreign currency headwind.

Equity

Nu Skin Enterprises Reports Fourth Quarter and Full-year 2024 Results Above Company Revenue Guidance

Nu Skin Enterprises Inc. (NYSE: NUS) today announced fourth quarter and full-year 2024 results above its latest revenue guidance. Executive Summary Q4 2024 vs. Prior-year Quarter Revenue $445.6...

Nu Skin Enterprises Announces Quarterly Dividend

Nu Skin Enterprises, Inc. (NYSE: NUS) today announced its board of directors has declared a quarterly cash dividend of $0.06 per share, which will be paid on March 5, 2025, to shareholders of record...

Nu Skin Enterprises Announces Q4 Preliminary Revenue at High End of Guidance

Nu Skin Enterprises Inc. (NYSE: NUS) today announced Q4 2024 preliminary revenue at the high end of the companys guidance range ahead of its presentation at the ICR Conference on Tuesday, Jan. 14...

Futures Rebound After Longest Losing Streak Since April

Futures Rebound After Longest Losing Streak Since April

 US equity futures posted modest gains suggesting stocks may finally halt a five-day losing streak, the longest since April...

Nu Skin Enterprises Announces Strategic Transaction of Mavely for $250 Million

Nu Skin Enterprises Inc. (NYSE: NUS) today announced that its Rhyz Inc. subsidiary completed a strategic transaction with Later, a portfolio company of Summit Partners. As part of the transaction...

Later Acquires Mavely for $250 Million, Unlocking New Opportunities for Marketers and Creators to Maximize their Return on Social

Later Acquires Mavely for $250 Million, Unlocking New Opportunities for Marketers and Creators to Maximize their Return on Social Later Acquires Mavely for $250 Million, Unlocking New Opportunities...

Nu Skin Enterprises Reports Third Quarter Results

Nu Skin Enterprises Inc. (NYSE: NUS) today announced third quarter results in line with guidance. Executive Summary Q3 2024 vs. Prior-year Quarter Revenue $430.1 million; (13.8)% (3.4)% FX impact or...

Nu Skin Enterprises, Inc. is a holding company, which engages in the development and distribution of beauty and wellness solutions. It operates through the following segments: Mainland China, Americas, South Korea, Southeast Asia/Pacific, EMEA, Japan, Hong Kong/Taiwan, Nu Skin Other, Manufacturing, and Rhyz Other. The company was founded by Blake M. Roney, Sandra N. Tillotson, and Steven J. Lund in 1984 and is headquartered in Provo, UT.

Nu Skin Enterprises, Inc. - Ordinary Shares - Class A

Will PepsiCo ($PEP) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

PepsiCo Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

NUS
Nu Skin Enterprises, Inc. - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest NUS News

NUS Nu Skin Enterprises, Inc. - Ordinary Shares - Class A